Delivery Order SPE2DB22D3501-SPE2DB24FUZ83
Award Date 3/21/24
Potential Completion Date 4/11/24
Potential Value $6.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with the ID SPE2DB22D2206|SPE2DB24FEA02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price, is for the supply of PADCEV 30 MG VIALS, a medical product. The contract has an ultimate completion date of November 28, 2023 and a ceiling value of $19,470.64. This award is not designated as a set-aside contract....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,345.32, is for the delivery of PADCEV 30 MG vials. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 30, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award, valued at $5,172.68, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the product "PADCEV 30 MG VIALS" and has an ultimate completion date of January 17, 2025. The contract was not designated with a set-aside requirement,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,931.65 firm fixed-price delivery order is for the provision of PADCEV 30 MG vials, a medical product. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the company to supply a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,175.20 Firm Fixed Price Delivery Order contract is for the supply of PADCEV 30 MG VIALS, a medical product, with a completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,338.30, is for the delivery of PADCEV 30 MG VIALS and has a completion date of December 26, 2023. The contract is a Firm Fixed Price Delivery Order and was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $21,904.47 with a Firm Fixed Price pricing type. The contract was awarded on October 26, 2023 with an ultimate completion date of November 17, 2023. The contract is for the supply of PADCEV 30 MG VIALS, a pharmaceutical product. This award is not designated as a set-aside contract....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,543.85 to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of PADCEV 30 MG VIALS, a pharmaceutical product, with a potential value of $24,999.30. The contract has a completion date of January 30, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has previously received...
- This federal contract award, with a ceiling value of $14,602.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product, with an ultimate completion date of April 11, 2023. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and was not designated under any set-aside program. Amerisourcebergen is the...